Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25124995 |
US |
||
Illness, Dyspnoea, |
||||
| 202 | 25125055 |
US |
61 | 2 |
Cough, Dyspnoea, Illness, Wheezing, Therapeutic product effect decreased, |
||||
DUPILUMAB, MONTELUKAST, |
||||
| 203 | 25125125 |
US |
72 | 1 |
Abdominal discomfort, Illness, Nausea, Vomiting, Abdominal distension, Asthenia, Off label use, |
||||
PACRITINIB, GABAPENTIN, LISINOPRIL, OXYCODONE, |
||||
| 204 | 25125145 |
US |
||
Illness, |
||||
RELUGOLIX, |
||||
| 205 | 25125233 |
US |
66 | 2 |
Seizure, Illness, |
||||
DUPILUMAB, |
||||
| 206 | 25125252 |
ZA |
44 | 2 |
Illness, Multiple sclerosis relapse, Drug ineffective, |
||||
SIPONIMOD, |
||||
| 207 | 25125260 |
US |
||
Immunodeficiency, Illness, |
||||
OCRELIZUMAB, |
||||
| 208 | 25125390 |
US |
57 | 2 |
Illness, |
||||
ADALIMUMAB, |
||||
| 209 | 25125408 |
US |
2 | |
Rheumatoid arthritis, Illness, Maternal exposure before pregnancy, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Intentional dose omission, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 210 | 25125467 |
CA |
51 | 2 |
Asthma, Head injury, Illness, Inappropriate schedule of product administration, Infection, Influenza, Pneumonia, Respiratory syncytial virus infection, Dyspnoea, Fall, Dizziness, |
||||
GABAPENTIN, MODAFINIL, MEPOLIZUMAB, MEPOLIZUMAB, MONTELUKAST, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 211 | 25126022 |
CA |
1 | |
Palpitations, Rhinorrhoea, Lower respiratory tract congestion, Hyperaesthesia teeth, Illness, Product dose omission issue, Dizziness, Nausea, Blood pressure abnormal, |
||||
BIMEKIZUMAB, |
||||
| 212 | 25126199 |
US |
63 | 2 |
Norovirus infection, Illness, Vomiting, Bronchitis, Influenza, |
||||
RISANKIZUMAB-RZAA, |
||||
| 213 | 25128727 |
58 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 214 | 25128759 |
59 | 1 | |
Illness, Infection, |
||||
UPADACITINIB, |
||||
| 215 | 25129394 |
67 | 2 | |
Illness, Therapy interrupted, Nausea, Asthenia, Depression, Weight decreased, Suicidal ideation, Product availability issue, |
||||
SEMAGLUTIDE, EVOLOCUMAB, LISDEXAMFETAMINE DIMESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, |
||||
| 216 | 25115592 |
CA |
42 | 2 |
Diarrhoea haemorrhagic, Osteoarthritis, Illness, Product dose omission issue, |
||||
INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, PREDNISONE, |
||||
| 217 | 25115796 |
US |
2 | |
Illness, Decreased appetite, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 218 | 25115886 |
US |
23 | 2 |
Illness, |
||||
FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, |
||||
| 219 | 25116049 |
CA |
46 | 2 |
Chills, Headache, Pyrexia, Dental restoration failure, Hypotension, Illness, Localised infection, Lung disorder, Pneumonia, Sepsis, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 220 | 25116108 |
US |
60 | 1 |
Illness, |
||||
IXEKIZUMAB, |
||||
| 221 | 25116194 |
US |
76 | 2 |
Rheumatoid arthritis, Cystitis, Feeling abnormal, Illness, Decreased immune responsiveness, Mobility decreased, Constipation, Asthenia, Abdominal discomfort, Product storage error, Intercepted product administration error, Therapy interrupted, |
||||
ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, |
||||
| 222 | 25116261 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
| 223 | 25116284 |
US |
66 | |
Device leakage, Product use issue, Inappropriate schedule of product administration, Feeling abnormal, Illness, Dyspnoea, |
||||
BENRALIZUMAB, |
||||
| 224 | 25116356 |
US |
1 | |
Illness, Cough, |
||||
SELEXIPAG, |
||||
| 225 | 25116475 |
US |
2 | |
Illness, Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 226 | 25116580 |
US |
2 | |
Illness, |
||||
TIRZEPATIDE, |
||||
| 227 | 25116593 |
US |
55 | 2 |
Weight decreased, Abdominal pain upper, Nausea, Feeding disorder, Illness, |
||||
SEMAGLUTIDE, INSULIN DEGLUDEC, |
||||
| 228 | 25116664 |
US |
1 | |
Illness, |
||||
NATALIZUMAB, |
||||
| 229 | 25116665 |
US |
69 | 2 |
Illness, |
||||
POMALIDOMIDE, |
||||
| 230 | 25116689 |
US |
2 | |
Illness, Malabsorption from administration site, Wrong device used, Infusion site bruising, Infusion site discomfort, |
||||
| 231 | 25116783 |
US |
74 | 2 |
Dyspnoea, Illness, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 232 | 25116794 |
US |
1 | |
Illness, Malaise, |
||||
PANCRELIPASE, |
||||
| 233 | 25117117 |
US |
82 | 2 |
Illness, |
||||
APIXABAN, APIXABAN, APIXABAN, APIXABAN, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, DICLOFENAC SODIUM AND MISOPROSTOL, EVOLOCUMAB, AMLODIPINE, AZELASTINE, |
||||
| 234 | 25117180 |
GB |
70 | 2 |
Illness, |
||||
CELECOXIB, CELECOXIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 235 | 25117455 |
GB |
68 | 1 |
Illness, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOPLATIN, LANSOPRAZOLE, AMLODIPINE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, LOSARTAN, UMECLIDINIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 236 | 25117524 |
GB |
2 | |
Malaise, Illness, Infection, |
||||
CLOZAPINE, |
||||
| 237 | 25117543 |
AR |
1 | |
Illness, Therapeutic product effect decreased, Cytokine release syndrome, |
||||
| 238 | 25117738 |
US |
2 | |
Illness, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 239 | 25117739 |
US |
||
Illness, |
||||
ORLISTAT, |
||||
| 240 | 25117798 |
US |
39 | 1 |
Illness, Gastroenteritis viral, |
||||
RISPERIDONE, |
||||
| 241 | 25117943 |
ZA |
84 | |
Illness, |
||||
DAPAGLIFLOZIN, FUROSEMIDE, BISOPROLOL FUMARATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, RIVAROXABAN, ROSUVASTATIN, |
||||
| 242 | 25117945 |
US |
2 | |
Illness, Asthma, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 243 | 25118112 |
US |
82 | 2 |
Macular oedema, Visual impairment, Illness, Dizziness, |
||||
PALBOCICLIB, ATENOLOL, LOSARTAN, |
||||
| 244 | 25118196 |
US |
30 | 2 |
Inflammatory carcinoma of the breast, Illness, Inappropriate schedule of product administration, Norovirus infection, Product distribution issue, Product temperature excursion issue, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 245 | 25118470 |
US |
32 | 2 |
Dysphonia, Illness, Dizziness, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 246 | 25118477 |
US |
59 | 1 |
Illness, Nasopharyngitis, Headache, Condition aggravated, |
||||
TOFACITINIB, |
||||
| 247 | 25118495 |
US |
40 | 2 |
Illness, |
||||
RITLECITINIB, |
||||
| 248 | 25118578 |
US |
||
Illness, Fatigue, Pain, Drug hypersensitivity, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 249 | 25118580 |
US |
2 | |
Illness, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 250 | 25118735 |
US |
||
Pneumonia, Bronchitis, Illness, Immunodeficiency, Dyspnoea, Respiratory muscle weakness, Device malfunction, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 251 | 25118762 |
US |
32 | 2 |
Nasopharyngitis, Ear infection, Seasonal allergy, Brain fog, Bronchitis, Inappropriate schedule of product administration, Product dose omission issue, Multiple allergies, Intervertebral disc protrusion, Illness, Pain, Influenza, Urinary tract infection, Oropharyngeal pain, Migraine, Infusion site pruritus, Fatigue, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SEMAGLUTIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, ERGOCALCIFEROL, EMPAGLIFLOZIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MELATONIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FLUTICASONE PROPIONATE, IRON, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, BUPROPION HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, NASAL, SALINE, (SALINE), EPINEPHRINE, ADRENALINUM, |
||||
| 252 | 25118770 |
ZA |
84 | |
Illness, |
||||
DAPAGLIFLOZIN, FUROSEMIDE, BISOPROLOL FUMARATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, RIVAROXABAN, ROSUVASTATIN, |
||||
| 253 | 25118802 |
US |
79 | 2 |
Illness, Muscular weakness, |
||||
TRIFLURIDINE AND TIPIRACIL, |
||||
| 254 | 25119081 |
US |
33 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
| 255 | 25119206 |
US |
4 | 2 |
Rebound eczema, Illness, |
||||
DUPILUMAB, |
||||
| 256 | 25119398 |
US |
41 | 1 |
Illness, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 257 | 25119528 |
US |
2 | |
Depressed level of consciousness, Illness, |
||||
RIBOCICLIB, |
||||
| 258 | 25119853 |
CA |
||
Pneumonia legionella, Sepsis, Illness, Condition aggravated, Decreased activity, Seasonal allergy, Viral infection, Nausea, Nausea, Abdominal pain, |
||||
ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 259 | 25119904 |
US |
2 | |
Illness, |
||||
DIMETHYL FUMARATE, |
||||
| 260 | 25119937 |
US |
49 | 2 |
Illness, Diarrhoea, |
||||
DULAGLUTIDE, |
||||
| 261 | 25119973 |
US |
52 | 2 |
Mental disorder, Illness, COVID-19, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 262 | 25120376 |
US |
53 | 2 |
Illness, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 263 | 25120571 |
US |
55 | 2 |
Gait inability, Metastases to lung, Speech disorder, Viral infection, Drug intolerance, Illness, Dyspnoea, Dyspnoea, |
||||
REGORAFENIB, REGORAFENIB, CAPECITABINE, |
||||
| 264 | 25120584 |
BR |
62 | 1 |
Chronic coronary syndrome, Cellulitis, Blood creatine phosphokinase increased, Eczema, Coronary artery disease, Neoplasm, Dyslipidaemia, Urticaria chronic, Blood cholesterol abnormal, Illness, Sciatica, Back pain, Feeling abnormal, |
||||
SIMVASTATIN, SIMVASTATIN, PAZOPANIB HYDROCHLORIDE, RANIBIZUMAB, INCLISIRAN, INCLISIRAN, INCLISIRAN, |
||||
| 265 | 25120741 |
US |
||
Cough, Illness, Pyrexia, |
||||
ELOSULFASE ALFA, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FAMOTIDINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALBUTEROL SULFATE, DEXTROSE MONOHYDRATE, DEXTROSE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LIDOCAINE, METHYLPREDNISOLONE, |
||||
| 266 | 25120816 |
US |
2 | |
Illness, Mental impairment, Dependence, |
||||
HYDROCODONE BITARTRATE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE, FENTANYL, HYDROCODONE BITARTRATE AND IBUPROFEN, |
||||
| 267 | 25120913 |
US |
||
Therapeutic product ineffective, Illness, Asthma, |
||||
BENRALIZUMAB, TEZEPELUMAB-EKKO, |
||||
| 268 | 25123177 |
44 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, |
||||
| 269 | 25123475 |
60 | 1 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 270 | 25123568 |
35 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 271 | 25124929 |
70 | 2 | |
Somnolence, Illness, Asthenia, Incoherent, Blood sodium decreased, Blood phosphorus decreased, Blood potassium decreased, |
||||
AVACOPAN, |
||||
| 272 | 25109758 |
IE |
61 | 2 |
Lower respiratory tract infection, Nasopharyngitis, Productive cough, Sinus disorder, Illness, |
||||
SECUKINUMAB, |
||||
| 273 | 25110088 |
US |
2 | |
Therapeutic response shortened, Illness, Multiple sclerosis relapse, Malaise, Vein collapse, Flushing, |
||||
NATALIZUMAB, |
||||
| 274 | 25110303 |
CA |
2 | |
Illness, COVID-19, Gastrointestinal haemorrhage, |
||||
PATIROMER, |
||||
| 275 | 25110388 |
US |
41 | 2 |
Suicidal ideation, Abnormal loss of weight, Migraine, Insomnia, Pain, Hypoaesthesia, Illness, Decreased appetite, Constipation, Diarrhoea, Vomiting, Product design confusion, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, |
||||
| 276 | 25110420 |
US |
64 | 1 |
Illness, Off label use, |
||||
POMALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BORTEZOMIB, |
||||
| 277 | 25110603 |
US |
2 | |
Illness, |
||||
NATALIZUMAB, |
||||
| 278 | 25110753 |
CN |
86 | 2 |
Temperature intolerance, Chills, Illness, Infusion related reaction, |
||||
DARATUMUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 279 | 25110863 |
US |
1 | |
Liver disorder, Illness, |
||||
ABEMACICLIB, |
||||
| 280 | 25110901 |
GB |
66 | 2 |
Illness, Infection, |
||||
| 281 | 25110923 |
GB |
2 | |
Colitis ulcerative, Illness, Drug ineffective, Food intolerance, Pain in extremity, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 282 | 25111109 |
US |
||
Illness, |
||||
ACALABRUTINIB, |
||||
| 283 | 25111206 |
US |
||
Illness, Cardiac disorder, Transient ischaemic attack, |
||||
DAPAGLIFLOZIN, |
||||
| 284 | 25111555 |
US |
||
Mood altered, Abdominal discomfort, Sleep disorder, Illness, Hyperhidrosis, Pain in extremity, Pain, Muscle twitching, Nausea, Constipation, Somnolence, Malaise, Insomnia, |
||||
PREGABALIN, |
||||
| 285 | 25111587 |
US |
||
Localised infection, Illness, Muscle strain, Vomiting, Inappropriate schedule of product administration, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 286 | 25111611 |
US |
28 | 2 |
Illness, Pyrexia, Nasopharyngitis, Fatigue, |
||||
SPARSENTAN, |
||||
| 287 | 25111669 |
US |
67 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
| 288 | 25111953 |
US |
68 | |
Illness, Intentional dose omission, |
||||
TOFACITINIB, |
||||
| 289 | 25112187 |
US |
2 | |
Neurological symptom, Adverse drug reaction, Illness, |
||||
PHENYTOIN, |
||||
| 290 | 25112374 |
US |
||
Dyspnoea, Illness, Drug dose omission by device, Device delivery system issue, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 291 | 25112506 |
US |
2 | |
Illness, |
||||
BIMEKIZUMAB, |
||||
| 292 | 25112569 |
US |
2 | |
Underdose, Tremor, Eye movement disorder, Dysarthria, Pain in extremity, Paraesthesia, Hypoaesthesia, Urinary incontinence, Constipation, Liver disorder, Reading disorder, Aphasia, Disturbance in attention, Balance disorder, Gait disturbance, Depressed mood, Hypersomnia, Initial insomnia, Slow speech, Restlessness, Somnolence, Illness, |
||||
DIROXIMEL FUMARATE, AMANTADINE, ATENOLOL, CYCLOBENZAPRINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 293 | 25112576 |
US |
2 | |
Illness, Inappropriate schedule of product administration, Off label use, |
||||
BIMEKIZUMAB, |
||||
| 294 | 25112586 |
US |
47 | 2 |
Illness, Respiratory tract infection, Cough, Nasal congestion, Rhinorrhoea, |
||||
BIMEKIZUMAB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, VITAMIN C, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 295 | 25112738 |
US |
54 | 1 |
Illness, Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 296 | 25112833 |
US |
53 | 1 |
Illness, Depression, |
||||
BIMEKIZUMAB, |
||||
| 297 | 25112839 |
US |
2 | |
Rash, Illness, Nasopharyngitis, Cough, Product availability issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 298 | 25112888 |
GB |
68 | 1 |
Illness, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOPLATIN, LANSOPRAZOLE, AMLODIPINE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, LOSARTAN, UMECLIDINIUM, ALBUTEROL SULFATE, ALBUTEROL, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, |
||||
| 299 | 25112910 |
US |
2 | |
Illness, Product availability issue, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 300 | 25112986 |
US |
1 | |
Illness, |
||||
BIMEKIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28